Moreover, inactivating mutations in PRKAR1A, initially described in Carney complex, can result in constitutive activation of the cAMP–protein kinase A pathway, leading to cortisol-producing adrenal tumors in sporadic cases [6]. This evidence concerns the gene PRKAR1A and adrenal gland neoplasm.